Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > FTC And Congress Ramp Up Efforts To Rein In Drug Patent Evergreening
Health and Wellness

FTC And Congress Ramp Up Efforts To Rein In Drug Patent Evergreening

Last updated: October 8, 2024 6:16 pm
Share
FTC And Congress Ramp Up Efforts To Rein In Drug Patent Evergreening
SHARE

The United States is facing a significant challenge when it comes to drug patent evergreening, a practice that extends patent rights on specific products to block generic and biosimilar competition. This issue has caught the attention of both the Federal Trade Commission (FTC) and Congress, who are now taking steps to address it.

The American patent system for pharmaceuticals is designed to incentivize innovation by allowing drug companies to sell new medications exclusively for a period of time before generics or biosimilars can enter the market. However, companies have found ways to extend their patent protection by filing secondary patents that cover aspects like dosages, formulations, and delivery mechanisms. This practice can grant them an additional three years of monopoly protection, leading to higher drug prices for consumers.

Recent studies have shown a significant increase in the number of patents filed by drug companies, many of which involve minor changes to existing drugs. While some of these changes can benefit patients, such as improving adherence and persistence, others are seen as abuses of the patent system. For example, companies have been known to file patents for insignificant items like a plastic strap attached to an inhaler, which has no direct impact on the drug itself.

The issue extends beyond inhalers, with nearly three-quarters of new drug patents issued between 2005 and 2015 being for pharmaceuticals already on the market. This practice has raised concerns about the hindrance of competition and the resulting impact on healthcare spending.

One area of particular focus for the FTC is biosimilars, which have the potential to significantly reduce healthcare costs. However, patent thickets, which create hurdles for generic and biosimilar competitors, have impeded their uptake. Bipartisan efforts are underway in Congress to address these issues, with multiple bills aimed at closing loopholes in the patent system.

See also  CDC Reports First Bird Flu Case With No Known Animal Exposure

Experts and policymakers are advocating for reforms that strike a balance between rewarding innovation and promoting competition to make prescription drugs more affordable. The Affordable Prescriptions for Patients Act, for example, seeks to limit patent thickets and product hopping, giving the FTC authority to enforce limits on patent litigation.

While the pharmaceutical industry defends its intellectual property rights, there is growing consensus that patent reform is necessary. The FTC has taken steps to challenge drug makers on improperly listed patents, but the effectiveness of these actions remains to be seen.

In conclusion, pressure is mounting for changes to the pharmaceutical patent system, and it remains to be seen how quickly these reforms will be implemented. With bipartisan support and regulatory scrutiny, the hope is that these efforts will lead to a more competitive and affordable drug market for consumers.

TAGGED:CongressDrugEffortsEvergreeningFTCpatentrampRein
Share This Article
Twitter Email Copy Link Print
Previous Article Why Josh Sargent is the USMNT striker Mauricio Pochettino wants to form a partnership with Christian Pulisic Why Josh Sargent is the USMNT striker Mauricio Pochettino wants to form a partnership with Christian Pulisic
Next Article An Art Dealer Bought This Painting at a Barn Sale for . It Turned Out to Be an Emily Carr Worth Nearly 0,000 An Art Dealer Bought This Painting at a Barn Sale for $50. It Turned Out to Be an Emily Carr Worth Nearly $150,000
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

A vegan Christmas

Mildreds, the iconic vegan restaurant in London, has recently unveiled its festive plant-based menu, curated…

December 16, 2024

The Best Memorial Day Sales on Appliances, Furniture and More

Are you looking to spruce up your home for the summer season? Memorial Day is…

May 24, 2025

Billie Lourd Shares Emotional Tribute To Late Mom Carrie Fisher

Billie Lourd Reflects on the Eighth Anniversary of Carrie Fisher's Death Actress Billie Lourd recently…

December 28, 2024

Wildfires Are Getting Worse. Trump’s Science Cuts Could Threaten Our Response. 

The Impact of Budget Cuts on Wildfire Preparedness As we approach the peak of wildfire…

May 21, 2025

Critical Metals (CRML) Soars to All-Time High as JPMorgan Sets Sights on Mineral Investments

We have recently unveiled a new article titled Monstrous Gains: 10 Stocks Leaving Wall Street…

October 17, 2025

You Might Also Like

NIH shuns studying racism and health. Its own research finds a link
Health and Wellness

NIH shuns studying racism and health. Its own research finds a link

October 31, 2025
Teen victim tied to Washington Square Park drug bust ID’d as recent grad who moved to NYC to start new life, internship
Crime

Teen victim tied to Washington Square Park drug bust ID’d as recent grad who moved to NYC to start new life, internship

October 31, 2025
As Medicaid work requirements loom, study finds links between coverage, better health and higher employment
Health and Wellness

As Medicaid work requirements loom, study finds links between coverage, better health and higher employment

October 31, 2025
Digital Twins Coming To Robotic Surgery
Health and Wellness

Digital Twins Coming To Robotic Surgery

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?